Feb 27, 2025
Crown Laboratories Announces Appointment of Adelle Walker as Chief Marketing Officer, Aesthetics
Feb 05, 2025
Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Jan 31, 2025
Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
Jan 21, 2025
Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
Dec 09, 2024
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
Sep 03, 2024
Crown Aesthetics Announces FDA Clearance of New SkinPen® Precision Elite
Aug 12, 2024
Crown Laboratories and Revance Announce Entry Into Merger Agreement
Jul 23, 2024
Crown Laboratories Announces Acquisition of Select Assets from Healeon LLC, A Subsidiary of Bimini Health Tech, A Global Leader in Innovative Medical Devices
Apr 30, 2024
Crown Laboratories Announces Expanded Role for Nadeem Moiz, President, Chief Operating Officer and Chief Financial Officer
Mar 21, 2024
SkinPen® Precision Wins Prestigious Aesthetics Awards 2024 for "Best Energy Device of the Year"
Feb 27, 2024
Crown Laboratories, Inc. Announces Strategic Consolidation of Business Units to Form a Unified Consumer Skincare Division
Jan 18, 2024
Sarna® Unveils Much Anticipated Rebrand and Reformulations of Its #1 Dermatologist-Recommended Topical Anti-Itch Lotions
Oct 05, 2020
Crown Laboratories Announces Commercialization of PanOxyl® PM Overnight Spot Patches